Yangping Wu

1.6k citations

22 papers · 933 indexed · 1 hit paper · h-index 14

Impact in

Cell Biology top 10%
- Microtubule and mitosis dynamics
- Cellular Mechanics and Interactions
Oncology top 10%

Papers in ⓘ

Molecular Biology 12
Oncology 11
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
- Cancer Immunotherapy and Biomarkers 2

Co-authors: Jinliang Yang (11 shared papers)Xi Chen (12 shared papers)Yuxi Wang (7 shared papers)Qiang Chen (3 shared papers)Yamei Yu (3 shared papers)Qinhuai Lai (4 shared papers)Benoı̂t Gigant (2 shared papers)Hang Zhang (3 shared papers)
Journals: Journal of Molecular Medicine (3 papers)Frontiers in Immunology (2 papers)European Journal of Medicinal Chemistry (1 paper)Clinical & Translational Oncology (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
Partner nations: China United States France

In The Last Decade

Yangping Wu

21 papers receiving 930 citations

Hit Papers

align trajectories log scale

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy 2021 · 176 citations

Peers

Countries citing papers authored by Yangping Wu

Since Specialization

Citations

This map shows the geographic impact of Yangping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangping Wu more than expected).

Fields of papers citing papers by Yangping Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangping Wu. The network helps show where Yangping Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yangping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yangping Wu Line = papers co-authored together Yangping Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery FEBS Journal ·Yuxi Wang, Hang Zhang, Benoı̂t Gigant, Yamei Yu, Yangping Wu, Xi Chen, Qinhuai Lai, Zhao-ya Yang, Qiang Chen, Jinliang Yang	2015	189
2	Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy Nature Biomedical Engineering ·Kewen Lei, Armand Kurum, Murat Kaynak, Lucia Bonati, Yulong Han, Veronika Cencen, Min Gao, Yuqing Xie, Yugang Guo, Mélanie T. M. Hannebelle, Yangping Wu, Guanyu Zhou, Ming Guo, Georg E. Fantner, Mahmut Selman Sakar, Li Tang Hit paper breakdown →	2021	176
3	Activity-based protein profiling: Recent advances in medicinal chemistry European Journal of Medicinal Chemistry ·Hui Deng, Qian Lei, Yangping Wu, Yang He, Weimin Li	2020	81
4	Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells Oncotarget ·Mingtian Wei, Tinghan Yang, Xi Chen, Yangping Wu, Xiangbing Deng, Wanbin He, Jinliang Yang, Ziqiang Wang	2017	64
5	Mechanism of microtubule stabilization by taccalonolide AJ Nature Communications ·Yuxi Wang, Yamei Yu, Guo‐Bo Li, Shuang Li, Chengyong Wu, Benoı̂t Gigant, Wenming Qin, Hao Chen, Yangping Wu, Qiang Chen, Jinliang Yang	2017	61
6	Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules Molecular Pharmacology ·Yuxi Wang, Frederick W. Benz, Yangping Wu, Qisheng Wang, Yunfeng Chen, Xi Chen, Huiyan Li, Yonghui Zhang, Rundong Zhang, Jinliang Yang	2015	58
7	Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling Journal of Cachexia Sarcopenia and Muscle ·Xi Chen, Yangping Wu, Tinghan Yang, Mingtian Wei, Yuxi Wang, Xiangbing Deng, Congcong Shen, Wenting Li, Hang Zhang, Weiyong Xu, Lantu Gou, Yong Zeng, Yonghui Zhang, Ziqiang Wang, Jinliang Yang	2016	40
8	Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines Journal of Molecular Medicine ·Yangping Wu, Xi Chen, Xiaojun Ge, Hongwei Xia, Yu-Xi Wang, Siyuan Su, Wenting Li, Tinghan Yang, Mingtian Wei, Hang Zhang, Lantu Gou, Jiong Li, Xian Jiang, Jinliang Yang	2015	39
9	Claudin‐2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription SHILAP Revista de lepidopterología ·Mingtian Wei, Yaguang Zhang, Xuyang Yang, Pingfan Ma, Yan Li, Yangping Wu, Xi Chen, Xiangbing Deng, Tinghan Yang, Xiaobing Mao, Lei Qiu, Wenjian Meng, Bo Zhang, Ziqiang Wang, Junhong Han	2021	39
10	Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer Signal Transduction and Targeted Therapy ·Hang Zhang, Yuxi Wang, Yangping Wu, Xiaohua Jiang, Yiran Tao, Yuqin Yao, Yujia Peng, Xi Chen, Yuyin Fu, Lin Yu, Ruixue Wang, Qinhuai Lai, Weirong Lai, Wenting Li, Yu‐Huan Kang, Shuli Yi, Ying Lu, Lantu Gou, Min Wu, Jinliang Yang	2017	32
11	Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling Journal of Molecular Medicine ·Xi Chen, Yangping Wu, Yangfu Jiang, Yan Zhou, Yuxi Wang, Yuqin Yao, Cheng Yi, Lantu Gou, Jinliang Yang	2012	30
12	Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma Frontiers in Cell and Developmental Biology ·Yuyin Fu, Yujia Peng, Shengyan Zhao, Jun Mou, Lishi Zeng, Xiaohua Jiang, Chengli Yang, Cheng Huang, Yuyan Li, Lu Yin, Mengdan Wu, Yanfang Yang, Ting Kong, Qinhuai Lai, Yangping Wu, Yuqin Yao, Yuxi Wang, Lantu Gou, Jinliang Yang	2021	29
13	Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model International Journal of Gynecological Cancer ·Yu Lin, Yuxi Wang, Yuqin Yao, Wenting Li, Qinhuai Lai, Jun Li, Yongjun Zhou, Tai‐Ran Kang, Yongmei Xie, Yangping Wu, Xi Chen, Yi Cheng, Lantu Gou, Jinliang Yang	2014	27
14	Polymorphisms in CISH Gene Are Associated with Persistent Hepatitis B Virus Infection in Han Chinese Population PLoS ONE ·Zhangyong Hu, Jinliang Yang, Yangping Wu, Xiong Guolian, Yali Wang, Jun J. Yang, Lan Deng	2014	14
15	Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for Lung Cancer in China BioMed Research International ·Chengdi Wang, Yuting Jiang, Qian Lei, Yangping Wu, Jun Shao, Dan Pu, Weimin Li	2019	13
16	High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma Clinical & Translational Oncology ·Tao Yu, Z. Wang, K. Liu, Yangping Wu, Jianchang Fan, JIN-XIU CHEN, C. Li, Guiquan Zhu, Longjiang Li	2013	13
17	CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15 Journal of Molecular Medicine ·Yixin Liu, Xi Chen, Ying Xu, Tinghan Yang, Haichuan Wang, Ziqiang Wang, Zhangyong Hu, Longqi Chen, Zheng Zhang, Yangping Wu	2023	9
18	Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance Vaccines ·Yixin Liu, Jianfeng Zhou, Yu‐Shang Yang, Xi Chen, Longqi Chen, Yangping Wu	2024	8
19	Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design Biochemical and Biophysical Research Communications ·Jie Cheng, Yangping Wu, Yuxi Wang, Chengdi Wang, Yanyan Wang, Chengyong Wu, Shaoxue Zeng, Yamei Yu, Qiang Chen	2017	6
20	DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis Frontiers in Immunology ·Yangping Wu, Wenting Li, Xi Chen, Haichuan Wang, Siyuan Su, Ying Xu, Xiangbing Deng, Tinghan Yang, Mingtian Wei, Li Li, Yixin Liu, Jinliang Yang, Weimin Li	2023	4

About Yangping Wu

Yangping Wu is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Organic Chemistry, having authored 22 papers that have together received 933 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune cells in cancer (3 papers), Synthesis and biological activity (2 papers), HER2/EGFR in Cancer Research (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Cell Biology (152 citations), Oncology (244 citations), Organic Chemistry (212 citations), Molecular Biology (509 citations) and Cancer Research (110 citations). Yangping Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Jinliang Yang, Xi Chen, Yuxi Wang, Qiang Chen, Yamei Yu, Qinhuai Lai, Benoı̂t Gigant, Hang Zhang, Qian Lei and Tinghan Yang. Their work appears in journals such as Journal of Molecular Medicine, Frontiers in Immunology, European Journal of Medicinal Chemistry, Clinical & Translational Oncology and Frontiers in Cell and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact